319 related articles for article (PubMed ID: 20869409)
21. Investigation of siRNA-loaded polyethylenimine-coated human serum albumin nanoparticle complexes for the treatment of breast cancer.
Abbasi S; Paul A; Prakash S
Cell Biochem Biophys; 2011 Nov; 61(2):277-87. PubMed ID: 21556941
[TBL] [Abstract][Full Text] [Related]
22. Intracellular trafficking and unpacking of siRNA/quantum dot-PEI complexes modified with and without cell penetrating peptide: confocal and flow cytometric FRET analysis.
Lee H; Kim IK; Park TG
Bioconjug Chem; 2010 Feb; 21(2):289-95. PubMed ID: 20078095
[TBL] [Abstract][Full Text] [Related]
23. Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes.
Kim SH; Lee SH; Tian H; Chen X; Park TG
J Drug Target; 2009 May; 17(4):311-7. PubMed ID: 19242850
[TBL] [Abstract][Full Text] [Related]
24. Effect of homobifunctional crosslinkers on nucleic acids delivery ability of PEI nanoparticles.
Swami A; Goyal R; Tripathi SK; Singh N; Katiyar N; Mishra AK; Gupta KC
Int J Pharm; 2009 Jun; 374(1-2):125-38. PubMed ID: 19446769
[TBL] [Abstract][Full Text] [Related]
25. A highly efficient siRNA carrier of PBLG modified hyperbranched PEI.
Chen J; Tian H; Guo Z; Xia J; Kano A; Maruyama A; Jing X; Chen X
Macromol Biosci; 2009 Dec; 9(12):1247-53. PubMed ID: 19890950
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
Wang J; Feng SS; Wang S; Chen ZY
Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205
[TBL] [Abstract][Full Text] [Related]
27. Cationic lipid-coated gold nanoparticles as efficient and non-cytotoxic intracellular siRNA delivery vehicles.
Kong WH; Bae KH; Jo SD; Kim JS; Park TG
Pharm Res; 2012 Feb; 29(2):362-74. PubMed ID: 21842305
[TBL] [Abstract][Full Text] [Related]
28. Amine-functionalized gold nanoparticles as non-cytotoxic and efficient intracellular siRNA delivery carriers.
Lee SH; Bae KH; Kim SH; Lee KR; Park TG
Int J Pharm; 2008 Nov; 364(1):94-101. PubMed ID: 18723087
[TBL] [Abstract][Full Text] [Related]
29. [Silence of VEGFR2 expression mediated by PEI/siRNA complexes].
Yang H; Che O; Chen S; Sun L; Ji AM
Yao Xue Xue Bao; 2010 May; 45(5):576-81. PubMed ID: 20931758
[TBL] [Abstract][Full Text] [Related]
30. Low molecular weight polyethylenimine conjugated gold nanoparticles as efficient gene vectors.
Hu C; Peng Q; Chen F; Zhong Z; Zhuo R
Bioconjug Chem; 2010 May; 21(5):836-43. PubMed ID: 20438071
[TBL] [Abstract][Full Text] [Related]
31. Acute in vivo toxicity mitigation of PEI-coated maghemite nanoparticles using controlled oxidation and surface modifications toward siRNA delivery.
Israel LL; Lellouche E; Ostrovsky S; Yarmiayev V; Bechor M; Michaeli S; Lellouche JP
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15240-55. PubMed ID: 26120905
[TBL] [Abstract][Full Text] [Related]
32. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery.
Ping Y; Liu C; Zhang Z; Liu KL; Chen J; Li J
Biomaterials; 2011 Nov; 32(32):8328-41. PubMed ID: 21840593
[TBL] [Abstract][Full Text] [Related]
33. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
[TBL] [Abstract][Full Text] [Related]
34. Size-dependent transfection efficiency of PEI-coated gold nanoparticles.
Cebrián V; Martín-Saavedra F; Yagüe C; Arruebo M; Santamaría J; Vilaboa N
Acta Biomater; 2011 Oct; 7(10):3645-55. PubMed ID: 21704738
[TBL] [Abstract][Full Text] [Related]
35. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis.
Jiang G; Park K; Kim J; Kim KS; Hahn SK
Mol Pharm; 2009; 6(3):727-37. PubMed ID: 19178144
[TBL] [Abstract][Full Text] [Related]
36. Enhanced siRNA delivery using oleic acid derivative of polyethylenimine.
Teng L; Xie J; Teng L; Lee RJ
Anticancer Res; 2012 Apr; 32(4):1267-71. PubMed ID: 22493358
[TBL] [Abstract][Full Text] [Related]
37. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
38. Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
Guo J; O'Driscoll CM; Holmes JD; Rahme K
Int J Pharm; 2016 Jul; 509(1-2):16-27. PubMed ID: 27188645
[TBL] [Abstract][Full Text] [Related]
39. Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis.
Park K; Hong SW; Hur W; Lee MY; Yang JA; Kim SW; Yoon SK; Hahn SK
Biomaterials; 2011 Jul; 32(21):4951-8. PubMed ID: 21481451
[TBL] [Abstract][Full Text] [Related]
40. A single-monomer derived linear-like PEI-co-PEG for siRNA delivery and silencing.
Tsai LR; Chen MH; Chien CT; Chen MK; Lin FS; Lin KM; Hwu YK; Yang CS; Lin SY
Biomaterials; 2011 May; 32(14):3647-53. PubMed ID: 21324524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
